Literature DB >> 30270928

Melanoma in situ: a case report from the patient's perspective.

Craig A Bauman1,2, Peter Emary3, Tyler Damen4, Heather Dixon1,2.   

Abstract

INTRODUCTION: Melanoma can be a fatal form of skin cancer. The prognosis rapidly deteriorates from the in situ stage (stage 0) to stage 4. As such, early detection and treatment are key. CASE
PRESENTATION: A middle-aged patient, who was also a chiropractor, self-identified a small skin lesion using the Chiropractors Guide to Skin Cancer. The primary care physician made a dermatology referral, and biopsy identified melanoma. Surgery was subsequently booked and the lesion was excised with a 5 mm margin. The final pathology report confirmed a diagnosis of melanoma in situ.
SUMMARY: As primary contact health care providers chiropractors can play a significant role in the potential identification and initiation of investigations into various possible dermatological disorders including skin cancer. Efforts should be made to diagnose melanoma at the in situ stage to ensure the best outcome.

Entities:  

Keywords:  chiropractic; melanoma; self-exam; skin cancer

Year:  2018        PMID: 30270928      PMCID: PMC6160896     

Source DB:  PubMed          Journal:  J Can Chiropr Assoc        ISSN: 0008-3194


  21 in total

Review 1.  Melanoma in situ: Part II. Histopathology, treatment, and clinical management.

Authors:  H William Higgins; Kachiu C Lee; Anjela Galan; David J Leffell
Journal:  J Am Acad Dermatol       Date:  2015-08       Impact factor: 11.527

2.  Melanoma risk in relation to height, weight, and exercise (United States).

Authors:  A R Shors; C Solomon; A McTiernan; E White
Journal:  Cancer Causes Control       Date:  2001-09       Impact factor: 2.506

3.  Mortality burden and prognosis of thin melanomas overall and by subcategory of thickness, SEER registry data, 1992-2013.

Authors:  Shoshana M Landow; Annie Gjelsvik; Martin A Weinstock
Journal:  J Am Acad Dermatol       Date:  2016-11-22       Impact factor: 11.527

4.  Alcohol Intake and Risk of Incident Melanoma: A Pooled Analysis of Three Prospective Studies in the United States.

Authors:  Andrew Rivera; Hongmei Nan; Tricia Li; Abrar Qureshi; Eunyoung Cho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12       Impact factor: 4.254

5.  Stress and melanoma: increasing the evidence towards a causal basis.

Authors:  Sudipta Sinnya; Brian De'Ambrosis
Journal:  Arch Dermatol Res       Date:  2013-06-06       Impact factor: 3.017

6.  Coffee drinking and cutaneous melanoma risk in the NIH-AARP diet and health study.

Authors:  Erikka Loftfield; Neal D Freedman; Barry I Graubard; Albert R Hollenbeck; Fatma M Shebl; Susan T Mayne; Rashmi Sinha
Journal:  J Natl Cancer Inst       Date:  2015-01-20       Impact factor: 13.506

7.  The "ugly duckling" sign: agreement between observers.

Authors:  Alon Scope; Stephen W Dusza; Allan C Halpern; Harold Rabinovitz; Ralph P Braun; Iris Zalaudek; Giuseppe Argenziano; Ashfaq A Marghoob
Journal:  Arch Dermatol       Date:  2008-01

8.  Acral lentiginous melanoma: incidence and survival patterns in the United States, 1986-2005.

Authors:  Porcia T Bradford; Alisa M Goldstein; Mary L McMaster; Margaret A Tucker
Journal:  Arch Dermatol       Date:  2009-04

9.  Evaluating invasive cutaneous melanoma: is the initial biopsy representative of the final depth?

Authors:  Pamela C Ng; David A Barzilai; Sahar A Ismail; Richard L Averitte; Anita C Gilliam
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

10.  The association between Parkinson's disease and melanoma: a systematic review and meta-analysis.

Authors:  Pei Huang; Xiao-Dong Yang; Sheng-Di Chen; Qin Xiao
Journal:  Transl Neurodegener       Date:  2015-11-03       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.